E-007 CLEVER: clinical evaluation of WEB 0.017 device in intracranial aneurysms - final results for ruptured and unruptured aneurysm at 12 months

ConclusionThese results show good efficacy and safety results at 12 months month, and no WEB related mortality at 12 months. These data confirm the safety and efficacy of WEB 0.017 use in intracranial aneurysm treatment, unruptured as well as ruptured, and are consistent with the results published up to date.Disclosures L. Spelle: 1; C; Philips. 2; C; Microvention, Stryker, Medtronic, Balt, Phenox. C. Cognard: 2; C; Stryker, Medtronic, Mivi, Cerenovus, Microvention. I. Szikora: 2; C; Stryker, Cerenovus, Medtronic, Microvention, Brainomix. F. Wodarg: 2; C; Microvention, Stryker, Cerus Endovascular, Balt, Johnson & Johnson, Acandis. V. Costalat: 2; C; Stryker, Medtronic, Microvention. D. Herbreteau: 2; C; Microvention. S. Fischer: 2; C; Rapid Medical, Microvention, Phenox, Stryker, Kaneka. M. Möhlenbruch: 1; C; Balt, Medtronic, Microvention, Stryker. 2; C; Siemens. C. Papagiannaki: 2; C; Medtronic, Microvention, Stryker. J. Klisch: 2; C; Microvention, Phenox, Cerus. R. Rautio: 2; C; Medtronic, Stryker, Microvention. A. Berlis: None. J. Downer: 1; C; Stryker, Microvention, Oxford Heartbeat. 2; C; Microvention. 3; C; Microvention, Stryker, Medtronic. M. Bester: 2; C; Microvention, Acandis. S. Velasco: None. T. Liebig: 2; C; Cerus endovascular, Stryker, Medtronic, Phenox, Microvention. J. Byrne: 1; C; Microvention. 2; C; Microvention, Oxford Endovascular Ltd. 4; C; Oxford Endovascular Ltd. L. Pierot: 2; C; Balt, Microvention, Phenox, Perflow, Vesalio.
Source: Journal of NeuroInterventional Surgery - Category: Neurosurgery Authors: Tags: SNIS 20th annual meeting electronic poster abstracts Source Type: research